These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 17185378)
1. Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells. Srinivasan S; Ranga RS; Burikhanov R; Han SS; Chendil D Cancer Res; 2007 Jan; 67(1):246-53. PubMed ID: 17185378 [TBL] [Abstract][Full Text] [Related]
2. A novel dietary triterpene Lupeol induces fas-mediated apoptotic death of androgen-sensitive prostate cancer cells and inhibits tumor growth in a xenograft model. Saleem M; Kweon MH; Yun JM; Adhami VM; Khan N; Syed DN; Mukhtar H Cancer Res; 2005 Dec; 65(23):11203-13. PubMed ID: 16322271 [TBL] [Abstract][Full Text] [Related]
3. Clioquinol, a therapeutic agent for Alzheimer's disease, has proteasome-inhibitory, androgen receptor-suppressing, apoptosis-inducing, and antitumor activities in human prostate cancer cells and xenografts. Chen D; Cui QC; Yang H; Barrea RA; Sarkar FH; Sheng S; Yan B; Reddy GP; Dou QP Cancer Res; 2007 Feb; 67(4):1636-44. PubMed ID: 17308104 [TBL] [Abstract][Full Text] [Related]
4. Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells. Altuwaijri S; Lin HK; Chuang KH; Lin WJ; Yeh S; Hanchett LA; Rahman MM; Kang HY; Tsai MY; Zhang Y; Yang L; Chang C Cancer Res; 2003 Nov; 63(21):7106-12. PubMed ID: 14612503 [TBL] [Abstract][Full Text] [Related]
5. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430 [TBL] [Abstract][Full Text] [Related]
6. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline. Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404 [TBL] [Abstract][Full Text] [Related]
7. GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms. Tepper CG; Vinall RL; Wee CB; Xue L; Shi XB; Burich R; Mack PC; de Vere White RW Prostate; 2007 Apr; 67(5):521-35. PubMed ID: 17252539 [TBL] [Abstract][Full Text] [Related]
8. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Mori A; Lehmann S; O'Kelly J; Kumagai T; Desmond JC; Pervan M; McBride WH; Kizaki M; Koeffler HP Cancer Res; 2006 Mar; 66(6):3222-9. PubMed ID: 16540674 [TBL] [Abstract][Full Text] [Related]
9. Development of an androgen receptor-null model for identifying the initiation site for androgen stimulation of proliferation and suppression of programmed (apoptotic) death of PC-82 human prostate cancer cells. Gao J; Isaacs JT Cancer Res; 1998 Aug; 58(15):3299-306. PubMed ID: 9699659 [TBL] [Abstract][Full Text] [Related]
10. Zanthoxyli Fructus induces growth arrest and apoptosis of LNCaP human prostate cancer cells in vitro and in vivo in association with blockade of the AKT and AR signal pathways. Yang Y; Ikezoe T; Takeuchi T; Adachi Y; Ohtsuki Y; Koeffler HP; Taguchi H Oncol Rep; 2006 Jun; 15(6):1581-90. PubMed ID: 16685399 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts. Chiu FL; Lin JK Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333 [TBL] [Abstract][Full Text] [Related]
12. Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway. Kim IY; Seong DH; Kim BC; Lee DK; Remaley AT; Leach F; Morton RA; Kim SJ Cancer Res; 2002 Jul; 62(13):3649-53. PubMed ID: 12097269 [TBL] [Abstract][Full Text] [Related]
13. 5-Azacitidine restores and amplifies the bicalutamide response on preclinical models of androgen receptor expressing or deficient prostate tumors. Gravina GL; Marampon F; Di Staso M; Bonfili P; Vitturini A; Jannini EA; Pestell RG; Tombolini V; Festuccia C Prostate; 2010 Aug; 70(11):1166-78. PubMed ID: 20333699 [TBL] [Abstract][Full Text] [Related]
14. Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells. Zhang X; Li W; Olumi AF Clin Cancer Res; 2007 Dec; 13(23):7181-90. PubMed ID: 18056199 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice. Wallner L; Dai J; Escara-Wilke J; Zhang J; Yao Z; Lu Y; Trikha M; Nemeth JA; Zaki MH; Keller ET Cancer Res; 2006 Mar; 66(6):3087-95. PubMed ID: 16540658 [TBL] [Abstract][Full Text] [Related]
16. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line. Lee SO; Dutt SS; Nadiminty N; Pinder E; Liao H; Gao AC Prostate; 2007 Sep; 67(12):1293-300. PubMed ID: 17626246 [TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin. Sánchez AM; Sánchez MG; Malagarie-Cazenave S; Olea N; Díaz-Laviada I Apoptosis; 2006 Jan; 11(1):89-99. PubMed ID: 16374544 [TBL] [Abstract][Full Text] [Related]
18. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells. Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523 [TBL] [Abstract][Full Text] [Related]
19. Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland. Gao S; Wang H; Lee P; Melamed J; Li CX; Zhang F; Wu H; Zhou L; Wang Z J Mol Endocrinol; 2006 Jun; 36(3):463-83. PubMed ID: 16720717 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models. Gravina GL; Marampon F; Giusti I; Carosa E; Di Sante S; Ricevuto E; Dolo V; Tombolini V; Jannini EA; Festuccia C Int J Oncol; 2012 Mar; 40(3):711-20. PubMed ID: 22134754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]